ImmPACT Bio’s $111 Million Series B Financing

Martina Bellini
Tagged:

Wilmer Cutler Pickering Hale and Dorr advised ImmPACT Bio on the deal.ImmPACT Bio, a clinical-stage company developing transformative logic-gate based chimeric antigen receptor (CAR) T-cell therapies…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now